title: Phase II trial with Flavone Acetic Acid (NSC.347512, LM975) in patients with non-small cell lung cancer.
authors.affiliation: Oncology Unit, Hôpital des Cadolles, Neuchâtel, Switzerland.
authors.forename: P
authors.initials: P
authors.lastname: Siegenthaler
authors.forename: S B
authors.initials: SB
authors.lastname: Kaye
authors.forename: S
authors.initials: S
authors.lastname: Monfardini
authors.forename: J
authors.initials: J
authors.lastname: Renard
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D004341:Drug Evaluation; D005260:Female; D005419:Flavonoids / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged
chemical_list: D000970:Antineoplastic Agents; D005419:Flavonoids; C049328:flavone acetic acid